For an adult weighing 87 kg, what are the recommended doses of tetanus immune globulin (anti‑tetanus serum) and tetanus toxoid vaccine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Tetanus Prophylaxis Dosing for 87 kg Adult

For an 87 kg adult requiring tetanus prophylaxis, administer 250 units of tetanus immune globulin (TIG) intramuscularly and 0.5 mL of tetanus toxoid-containing vaccine (Td or Tdap) intramuscularly at separate sites—these doses are weight-independent for adults. 1

Dosing Specifics

Tetanus Immune Globulin (TIG)

  • Standard adult dose: 250 units IM 2, 1
  • This dose is not weight-based for adults and children ≥7 years old
  • For children <7 years, dosing can be calculated at 4.0 units/kg, though administering the full 250 units regardless of size is often advisable 1
  • At 87 kg, the weight-based calculation (348 units) is irrelevant—the standard 250-unit dose applies

Tetanus Toxoid Vaccine

  • Standard adult dose: 0.5 mL IM (contains 5 Lf tetanus toxoid in Td formulation) 3
  • Use Tdap if the patient has never received it (preferred for first dose) 4
  • Use Td for subsequent boosters or if Tdap was previously given 4
  • This dose is not weight-based for any age group

Administration Technique

Critical: Administer TIG and tetanus toxoid at separate anatomical sites using different syringes 2, 1. This prevents the immune globulin from interfering with active immunization, though evidence shows absorbed tetanus toxoid with human immunoglobulin has minimal interference 5, 6.

Clinical Decision Algorithm

When to Give TIG (250 units):

  • Uncertain or incomplete primary vaccination series (fewer than 3 doses lifetime) AND tetanus-prone wound 2
  • Never give TIG alone—always pair with tetanus toxoid to initiate active immunity 2

When to Give Tetanus Toxoid Only:

  • Complete primary series documented (≥3 doses lifetime):
    • Clean, minor wounds: Give toxoid if >10 years since last dose 4
    • All other wounds: Give toxoid if >5 years since last dose 4

Mass Casualty Caveat:

In resource-limited settings, reserve TIG for patients >60 years old or immigrants from non-North American/European regions, as these groups are least likely to have adequate baseline immunity 2.

Follow-Up Requirements

If this is the first dose of a primary series, the patient must complete:

  • Second dose: ≥4 weeks after first dose
  • Third dose: 6-12 months after first dose 4

Impress upon the patient that a single injection does not provide complete protection—the full 3-dose series is mandatory for adequate immunity 1.

Common Pitfalls to Avoid

  • Do not use weight-based dosing for adults—the 250-unit TIG dose is standard regardless of body weight
  • Do not give TIG without toxoid—this provides only temporary passive immunity without establishing active protection
  • Do not assume wound appearance predicts tetanus risk—tetanus can occur after minor injuries, and wound characteristics are unreliable predictors 7
  • Do not delay toxoid administration thinking it protects the current injury—it primarily protects against future exposures, though it should still be given promptly 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.